by GlobeNewsWire | Aug 3, 2016 | Globe Newswire
MEDFORD, N.Y., Aug. 03, 2016 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases (“Chembio” or the “Company”), announced today the completion of an underwritten public offering of...
by GlobeNewsWire | Jul 14, 2016 | Globe Newswire
— Avid Contract Manufacturing Revenues Increased 66% to $44.4 Million with a Revenue Backlog of $68 Million Heading into Fiscal Year 2017 —- Growing Biomanufacturing Demand Prompts Plans for Third Manufacturing Facility Expected to be Commissioned by...
by GlobeNewsWire | Jun 2, 2016 | Globe Newswire
– Contract Manufacturing Revenue Hits All-Time High of $44 Million for Fiscal Year Ended April 2016; Fiscal Year 2017 Contract Manufacturing Revenue Projected Between $50-55 Million; Continued Growth Expected to Lead to Future Sustainable Profitability in 24...
by GlobeNewsWire | Jun 1, 2016 | Featured, Globe Newswire
MEDFORD, N.Y., June 01, 2016 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced the launch of U.S. sales of its Chembio-branded SURE CHECK® HIV 1/2 Assay. In...
by GlobeNewsWire | May 12, 2016 | Globe Newswire
MEDFORD, N.Y., May 12, 2016 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial results for the three months ended March 31, 2016. John J. Sperzel III,...